SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Gwen Ifill
| Patient | Gwen Ifill |
|---|
| Date of birth | 1965-09-29 |
|---|
| Identifiers | MRN HR-ML032-SYN; SSN (made up) 000-32-5814 |
|---|
| Document date | 2026-01-05 |
|---|
| Author | Lorna Achebe-Price, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Visit
Three weeks of postmenopausal bleeding in a woman of 60: examination, office endometrial biopsy, transvaginal ultrasound, and gynecologic oncology review booked [S]
History of Present Illness
This fictional modern episode addresses the presenting concerns below. [S]
- Spotting, then light bleeding on and off for about three weeks, eight years after her periods stopped; no pain. [S]
- She does not want a wait-and-see answer: she knows that bleeding after menopause is sometimes put down to nothing, and she wants the cause found quickly and told plainly. [S]
- She wants to keep working and to decide who is told. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Gwendolyn Ifill was born in Queens, New York, on September 29, 1955, the fifth of six children. Her father, a Panamanian immigrant, became a pastor in the African Methodist Episcopal Church; her mother was from Barbados. The family moved around the Northeast for her father's work and for a time lived in federally subsidized housing. [D]
- She graduated from Simmons College in Boston in 1977. As a college intern at the Boston Herald American she found a racist note left for her; the paper's editors hired her after she graduated. She went on to report for the Baltimore Evening Sun, The Washington Post, The New York Times and NBC News. [D]
- In 1999 she became moderator of PBS's Washington Week in Review, the first African American woman to host a major national political talk show, and a senior correspondent for the NewsHour. In 2013 she and Judy Woodruff were named co-anchors of the PBS NewsHour, the first women to jointly lead a national nightly news broadcast. [D]
- She moderated the vice-presidential debates of 2004 and 2008. In the 2004 debate she asked the candidates about AIDS in the United States, citing the much higher death rate among Black women aged 25 to 44. She wrote The Breakthrough: Politics and Race in the Age of Obama (2009). [D]
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Journalist and co-anchor of a nightly national news program; also moderates a weekly political program; long working days and frequent travel in an election year [S]
- Lives alone in Washington, D.C.; has no children. Supports: a large extended family she is close to, many friends, and her church community [S]
- Very private about her health: wants information shared only with the people she chooses, and wants to keep working through treatment if she can [S]
- Never smoker; alcohol occasionally, within low-risk limits; no drug use [S]
- Menstrual history: last period about eight years ago; no menopausal hormone therapy, tamoxifen or other hormone use [S]
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Review of Systems
Positive for the concerns in the history of present illness. Alert, direct and precise; asks pointed questions and wants the facts plainly; PHQ-2 negative; no thoughts of self-harm. No other systems reported as affected in this synthetic episode. [S]
General Status
Alert and engaged. Independent and working full time; walks most days. [S]
Physical Exam
Vital signs recorded on 2026-01-05; see the Vital Signs section. Mental status: Alert, direct and precise; asks pointed questions and wants the facts plainly; PHQ-2 negative; no thoughts of self-harm. The physical examination is limited to the findings relevant to this synthetic episode. [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-01-05 | Body height | 165 | cm | S |
| 2026-01-05 | Body weight | 74.6 | kg | S |
| 2026-01-05 | Body mass index (BMI) [Ratio] | 27.4 | kg/m2 | S |
| 2026-01-05 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-01-05 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-01-05 | Heart rate | 78 | /min | S |
| 2026-01-05 | Respiratory rate | 16 | /min | S |
| 2026-01-05 | Body temperature | 36.7 | Cel | S |
| 2026-01-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-01-05 | Hemoglobin [Mass/volume] in Blood | 11.8 | g/dL | 12-15.5 g/dL | Low | S |
| 2026-01-05 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-01-05 | Platelets [#/volume] in Blood by Automated count | 268 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-01-05 | Creatinine [Mass/volume] in Serum or Plasma | 0.82 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-01-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 82 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-01-05 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-05 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | Normal | S |
| 2026-01-05 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | | | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Postmenopausal bleeding for three weeks, about eight years after her last period, in a woman of 60 who takes no hormone therapy: endometrial cancer must be excluded. Office endometrial biopsy taken today, transvaginal ultrasound this week, and gynecologic oncology review booked | active | confirmed |
N95.0 | S — Synthetic presenting problem; no symptom of her real illness was made public. Superseded by the diagnosis at the gynecologic oncology consultation. |
Assessment
- Postmenopausal bleeding for three weeks, about eight years after her last period, in a woman of 60 who takes no hormone therapy: endometrial cancer must be excluded. Office endometrial biopsy taken today, transvaginal ultrasound this week, and gynecologic oncology review booked: active, confirmed [S]
Plan of Treatment
- Gynecologic oncology consultation within two weeks to review the endometrial biopsy and ultrasound with her and plan treatment if cancer or atypical hyperplasia is found. Guideline: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms (2026); Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding. Obstet Gynecol 2026;148(1):e87-e91 (PMID 41990335) (2026) [S]
- Any bleeding after menopause is evaluated: speculum and bimanual examination, office endometrial biopsy at the first visit, and transvaginal ultrasound within the week, both done rather than relying on endometrial thickness alone; blood count and A1c; results by telephone within days, not at a routine visit. Guideline: Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding. Obstet Gynecol 2026;148(1):e87-e91 (PMID 41990335) (2026); Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding. Obstet Gynecol 2018;131(5):e124-e129 (PMID 29683909) (2018); Clarke MA, et al. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype. JAMA Oncol 2022;8(6):895-903 (PMID 35511145) (2022); Doll KM, et al. Assessment of Prediagnostic Experiences of Black Women With Endometrial Cancer in the United States. JAMA Netw Open 2020;3(5):e204954 (PMID 32412636) (2020) [S]
- Distress and depression screening at each visit, plain explanations, written information, and support she chooses; she decides who receives each note. Guideline: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms (2026); Depression and Suicide Risk in Adults: Screening (2023) [S]
- Referral to gynecologic oncology, Miriam Delacroix, MD, ordered 2026-01-05 [S]